StreetInsider.com News Articles

Telescope Innovations CTO Prof. Jason Hein to Attend Invitation-Only NSF Programmable Cloud Laboratories Kickoff in Washington, DC

Wed, 23 Sep 2026 08:00:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - September 23, 2026) - Telescope Innovations Corp. (CSE: TELI), (OTCQB: TELIF), (FSE: J4U), ("Telescope" or the "Company"), a leading developer of Physical AI systems, including Self-Driving Laboratories, and enabling technologies and services for the global pharmaceutical and high-value chemical industries, announces that Chief Technology Officer Prof. Jason Hein has been requested to participate in the National Science Foundation Programmable Cloud Laboratories ("NSF PCL") Test Bed Kickoff Meeting, an invitation-only summit taking place September 24 to 25, 2026 in Washington, DC.

The NSF PCL Test Bed is a US$380 million initiative funding 20 teams to build a

Telescope Innovations CTO Prof. Jason Hein to Attend Invitation-Only NSF Programmable Cloud Laboratories Kickoff in Washington, DC

Wed, 23 Sep 2026 08:00:00 -0400

The NSF PCL Test Bed is a US$380 million initiative funding 20 teams to build a

Telescope Innovations CTO Prof. Jason Hein to Attend Invitation-Only NSF Programmable Cloud Laboratories Kickoff in Washington, DC

Wed, 23 Sep 2026 08:00:00 -0400

The NSF PCL Test Bed is a US$380 million initiative funding 20 teams to build a

Telescope Innovations CTO Prof. Jason Hein to Attend Invitation-Only NSF Programmable Cloud Laboratories Kickoff in Washington, DC

Wed, 23 Sep 2026 08:00:00 -0400

The NSF PCL Test Bed is a US$380 million initiative funding 20 teams to build a

Telescope Innovations names Dr. Neil Lewis to its board

Wed, 19 Aug 2026 08:02:17 -0400

Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) announced the appointment of Dr. Neil Lewis to its Board of Directors, effective August 19, 2026.

Dr. Lewis holds a PhD in chemistry from the Polytechnic of Wales and completed a postdoctoral fellowship at the National Institutes of Health (NIH), where he was tenured in 1992 as a Senior Biophysical Researcher. He is a Fellow of the Royal Society of Chemistry, a Chartered Chemist, and a Fellow of the Society of Applied Spectroscopy.

Dr. Lewis has founded or co-founded three technology companies, including Spectral Dimensions, Inc., which developed chemical imaging systems for the

Telescope Announces Appointment of Dr. E. Neil Lewis to the Board of Directors

Wed, 19 Aug 2026 08:00:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - August 19, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) (the "Company" or "Telescope"), a leading developer of Physical AI systems, including Self-Driving Laboratories, and enabling technologies and services for the global pharmaceutical and high-value chemical industries, is pleased to announce the appointment of Dr. Neil Lewis to its Board of Directors (the "Board"), effective August 19, 2026.

Dr. Lewis received his PhD in chemistry from the Polytechnic of Wales in the UK and did his postdoctoral fellowship at the National Institutes of Health (NIH) in the USA. He was tenured by

Telescope Announces Appointment of Dr. E. Neil Lewis to the Board of Directors

Wed, 19 Aug 2026 08:00:00 -0400

Dr. Lewis received his PhD in chemistry from the Polytechnic of Wales in the UK and did his postdoctoral fellowship at the National Institutes of Health (NIH) in the USA. He was tenured by

Telescope Innovations board member resigns, to stay on as consultant

Tue, 14 Jul 2026 19:33:09 -0400

Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) announced that Ali Pejman has resigned from its Board of Directors, effective July 14, 2026.

Pejman will remain engaged with the Vancouver, British Columbia-based company under a consulting agreement to be finalized shortly after his departure from the board.

Henry Dubina, CEO, said: "On behalf of the Board and management, I would like to thank Ali for his commitment and the thoughtful guidance he has provided during an important period in the Company's growth. We are pleased that he will continue to support Telescope as a consultant, and we wish him every success."

The

Telescope Announces Changes to its Board of Directors

Tue, 14 Jul 2026 19:32:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - July 14, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company"), a leading developer of intelligent automation and advanced chemical manufacturing technologies, announces that Ali Pejman has resigned from the Company's Board of Directors ("Board"), effective as of the date of this press release.

Henry Dubina, CEO, stated, "On behalf of the Board and management, I would like to thank Ali for his commitment and the thoughtful guidance he has provided during an important period in the Company's growth. We are pleased that he will continue to support Telescope as a consultant,

Telescope Announces Changes to its Board of Directors

Tue, 14 Jul 2026 19:32:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - July 14, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company"), a leading developer of intelligent automation and advanced chemical manufacturing technologies, announces that Ali Pejman has resigned from the Company's Board of Directors ("Board"), effective as of the date of this press release.
Henry Dubina, CEO, stated, "On behalf of the Board and management, I would like to thank Ali for his commitment and the thoughtful guidance he has provided during an important period in the Company's growth. We are pleased that he will continue to support Telescope as a consultant,

Telescope Innovations to Attend Fastmarkets Global Lithium, Battery & Critical Materials in Las Vegas

Tue, 23 Jun 2026 08:00:00 -0400

The Company will use the conference to advance commercial discussions around Self-Driving Labs, automated sampling systems, and lithium sulfide materials licensing
Vancouver, British Columbia--(Newsfile Corp. - June 23, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company"), a developer of intelligent automation and advanced chemical manufacturing technologies, is pleased to announce that it will be attending the Fastmarkets Global Lithium, Battery & Critical Materials conference in Las Vegas, Nevada from June 23-25, 2026.
The conference is one of the sector's leading annual meeting points for participants across the lithium, battery materials, and broader critical minerals value chain,

Telescope Innovations to Attend Fastmarkets Global Lithium, Battery & Critical Materials in Las Vegas

Tue, 23 Jun 2026 08:00:00 -0400

The Company will use the conference to advance commercial discussions around Self-Driving Labs, automated sampling systems, and lithium sulfide materials licensing
Vancouver, British Columbia--(Newsfile Corp. - June 23, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company"), a developer of intelligent automation and advanced chemical manufacturing technologies, is pleased to announce that it will be attending the Fastmarkets Global Lithium, Battery & Critical Materials conference in Las Vegas, Nevada from June 23-25, 2026.
The conference is one of the sector's leading annual meeting points for participants across the lithium, battery materials, and broader critical minerals value chain,

Telescope Innovations Provides Financial Results of Third Fiscal Quarter 2026

Tue, 16 Jun 2026 08:00:00 -0400

Year-to-date revenues are 80% higher than comparative values for previous fiscal year
Vancouver, British Columbia--(Newsfile Corp. - June 16, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE:J4U) ("Telescope" or the "Company"), a developer of advanced technologies and services for the global pharmaceutical and chemical industries, reports financial results for the fiscal quarter ended May 31, 2026 (Q3 FY2026). The Company generated revenues of approximately $2.1 million during this period, driven by a combination of contract services and Self-Driving Lab ("SDL") projects, with an adjusted EBITA loss of $1.1 million. Year-to-date gross revenues increased to $6.5 million compared with $3.6

Telescope Innovations Provides Financial Results of Third Fiscal Quarter 2026

Tue, 16 Jun 2026 08:00:00 -0400

Year-to-date revenues are 80% higher than comparative values for previous fiscal year
Vancouver, British Columbia--(Newsfile Corp. - June 16, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE:J4U) ("Telescope" or the "Company"), a developer of advanced technologies and services for the global pharmaceutical and chemical industries, reports financial results for the fiscal quarter ended May 31, 2026 (Q3 FY2026). The Company generated revenues of approximately $2.1 million during this period, driven by a combination of contract services and Self-Driving Lab ("SDL") projects, with an adjusted EBITA loss of $1.1 million. Year-to-date gross revenues increased to $6.5 million compared with $3.6

Telescope Innovations to Present at the Planet MicroCap Las Vegas Powered by MicroCapClub

Thu, 11 Jun 2026 08:00:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - June 11, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company"), a leading developer of intelligent automation and advanced chemical manufacturing technologies, is pleased to announce it will be presenting at the Planet MicroCap Las Vegas 2026 conference on Wednesday, June 17^th, 2026.
At Planet MicroCap, Dr. Jeffrey Sherman will provide an update on Telescope's business including its DirectInject-LC™ reaction sampling products, a newly announced technology development collaboration with AGI SDA to develop next-generation automated chemistry reactors (see news release dated March 16, 2026), and the Company's growing roster of

Telescope Innovations to Present at the Planet MicroCap Las Vegas Powered by MicroCapClub

Thu, 11 Jun 2026 08:00:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - June 11, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company"), a leading developer of intelligent automation and advanced chemical manufacturing technologies, is pleased to announce it will be presenting at the Planet MicroCap Las Vegas 2026 conference on Wednesday, June 17^th, 2026.
At Planet MicroCap, Dr. Jeffrey Sherman will provide an update on Telescope's business including its DirectInject-LC™ reaction sampling products, a newly announced technology development collaboration with AGI SDA to develop next-generation automated chemistry reactors (see news release dated March 16, 2026), and the Company's growing roster of

Telescope Innovations Founder and CTO, Professor Jason Hein, Receives 2026 SCI Canada LeSueur Memorial Award

Fri, 05 Jun 2026 08:00:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - June 5, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company") congratulates its Founder and Chief Technology Officer, Professor Jason Hein, on receiving the 2026 SCI Canada LeSueur Memorial Award from the Society of Chemical Industry ("SCI").

Figure 1. The 2026 LeSeueur Memorial Award Presented to Professor Jason Hein
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/8923/300261_328197891408ab84_001full.jpg
Administered by the Society of Chemical Industry, a professional body founded in London in

Telescope Innovations Founder and CTO, Professor Jason Hein, Receives 2026 SCI Canada LeSueur Memorial Award

Fri, 05 Jun 2026 08:00:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - June 5, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company") congratulates its Founder and Chief Technology Officer, Professor Jason Hein, on receiving the 2026 SCI Canada LeSueur Memorial Award from the Society of Chemical Industry ("SCI").

Figure 1. The 2026 LeSeueur Memorial Award Presented to Professor Jason Hein
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/8923/300261_328197891408ab84_001full.jpg
Administered by the Society of Chemical Industry, a professional body founded in London in

Telescope Innovations Secures Third Self-Driving Lab Deployment with Major Global Pharmaceutical Company

Mon, 01 Jun 2026 08:00:00 -0400

Continued adoption by world-leading pharmaceutical partners underscores growing industry demand for autonomous lab technology
Vancouver, British Columbia--(Newsfile Corp. - June 1, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company"), a leading developer of intelligent automation and advanced chemical manufacturing technologies, today announced that is has signed an agreement with a major global pharmaceutical company to deliver a Self-Driving Lab (SDL) platform at the company's European operations. The deployment, Telescope's third SDL placement in its 2026 fiscal year, is expected to be installed within the coming months.
A MILESTONE BUILDING ON TWO PRIOR SUCCESSES
The agreement

Telescope Innovations Secures Third Self-Driving Lab Deployment with Major Global Pharmaceutical Company

Mon, 01 Jun 2026 08:00:00 -0400

Continued adoption by world-leading pharmaceutical partners underscores growing industry demand for autonomous lab technology
Vancouver, British Columbia--(Newsfile Corp. - June 1, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company"), a leading developer of intelligent automation and advanced chemical manufacturing technologies, today announced that is has signed an agreement with a major global pharmaceutical company to deliver a Self-Driving Lab (SDL) platform at the company's European operations. The deployment, Telescope's third SDL placement in its 2026 fiscal year, is expected to be installed within the coming months.
A MILESTONE BUILDING ON TWO PRIOR SUCCESSES
The agreement

Telescope Innovations Shares Spring 2026 Conference and Events Lineup

Mon, 11 May 2026 08:00:00 -0400

The Company is actively engaging with pharmaceutical, academic, and investor audiences to strengthen existing and novel partnerships
Vancouver, British Columbia--(Newsfile Corp. - May 11, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company") is a developer of enabling technologies and services for the global pharmaceutical and high value chemical industries. The Company is pleased to report on outreach, marketing, and educational activities, both past and planned for spring 2026. Our participation includes presentations, exhibitions and keynote lectures on our advanced automation technology for chemical R&D: Self-Driving Labs, and DirectInject-LC™.
Telescope" or the "Company") is a developer of enabling technologies and services for the global pharmaceutical and high value chemical industries. The Company is pleased to report on outreach, marketing, and educational activities, both past and planned for spring 2026. Our participation includes presentations, exhibitions and keynote lectures on our advanced automation technology for chemical R&D: Self-Driving Labs, and DirectInject-LC™.
Telescope" or the "Company"), a developer of advanced technologies and services for the global pharmaceutical and chemical industries, reports financial results for the fiscal quarter ended February 28, 2026 (Q2 FY2026). The Company generated revenues of approximately $1.6 million during this period, with strong contributions from the development and delivery of Self-Driving Laboratories (SDL), with an adjusted EBITA loss of $0.7 million consistent with management's expectations. Year-to-date gross revenues increased

Telescope Innovations Provides Financial Results of Second Fiscal Quarter 2026

Mon, 13 Apr 2026 18:00:00 -0400

Revenues are consistent with budget expectations and ahead of Q2 2025 comparative revenues
Vancouver, British Columbia--(Newsfile Corp. - April 13, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company"), a developer of advanced technologies and services for the global pharmaceutical and chemical industries, reports financial results for the fiscal quarter ended February 28, 2026 (Q2 FY2026). The Company generated revenues of approximately $1.6 million during this period, with strong contributions from the development and delivery of Self-Driving Laboratories (SDL), with an adjusted EBITA loss of $0.7 million consistent with management's expectations. Year-to-date gross revenues increased

Telescope Innovations Announces Expansion of Consulting Role for Dr. Joel M. Hawkins, Industry Leader in Process Chemistry Automation

Mon, 23 Mar 2026 08:00:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - March 23, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company") is a developer of enabling technologies and services for the global pharmaceutical and high value chemical industries. The Company is pleased to announce that Dr. Joel M. Hawkins has expanded his consulting role with Telescope. Dr. Hawkins is an industry-wide authority in automating complex chemistry workflows and enabling the high-value kinetic and mechanistic datasets needed for chemical process development. His expertise will now support Telescope's expanding work in automated chemistry sampling technologies and autonomous, Self-Driving Laboratories.
Dr. Hawkins has been